$PFE News A tale of two drug companies 4:13 p.m.
Post# of 102254
Posted On: 12/06/2013 12:29:51 PM
$PFE News
A tale of two drug companies 4:13 p.m. Dec. 5, 2013 - Mark Hulbert
3 low-risk stocks for market skeptics 6:15 a.m. Dec. 5, 2013 - Jeff Reeves
DuPont, Pfizer are top decliners in Dow index 4:01 p.m. Dec. 3, 2013 - Polya Lesova
Large-caps can boost your portfolio at year-end 2:58 p.m. Nov. 22, 2013 - Mark Hulbert
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
Where's the market oopmh? Cisco and a turnaround on Exxon Mobil 8:45 a.m. Nov. 13, 2013 - blogs.marketwatch.com
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch
U.S. stocks open higher; Pfizer rises 1% 9:36 a.m. Oct. 29, 2013 - Victor Reklaitis
Stock futures up slightly ahead of Fed meeting 9:04 a.m. Oct. 29, 2013 - Sara Sjolin
Pfizer profit falls, adjusts full-year views 7:24 a.m. Oct. 29, 2013 - MarketWatch.com
Pfizer net falls, adjusts full-year earnings range 7:18 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 revenue down 2% to $12.64 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 profit falls 19% to $2.59 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Adopts PhRMA’s Transparency Prescription 3:47 p.m. Dec. 5, 2013 - Wall St. Cheat Sheet
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy 12:43 p.m. Dec. 5, 2013 - Seeking Alpha
Pfizer to broaden access to clinical trial data 12:40 p.m. Dec. 5, 2013 - Seeking Alpha
Breast Cancer Drug Data Boosts Puma Biotechnology 10:15 a.m. Dec. 5, 2013 - Investors Business Daily
Goldman Sachs Removes Pfizer And Adds AbbVie To Its Conviction Buy List: Should You? 7:50 a.m. Dec. 5, 2013 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Stocks vs. Bonds 8:24 p.m. Dec. 4, 2013 - TheStreet.com
Companies Say Goodbye to the 'Burbs 8:21 p.m. Dec. 4, 2013 - WSJ.com
Pfizer: Transformation Pace And Oncology Success Determine Potential Returns 4:40 p.m. Dec. 4, 2013 - Seeking Alpha
Pfizer cuts 150 jobs in Ireland 3:16 p.m. Dec. 4, 2013 - Seeking Alpha
Pfizer Expands Clinical Trial Data Access Policy, Launches Data Access Portal 11:10 a.m. Dec. 4, 2013 - benzinga.com
Meet the Preliminary 2014 Dogs of the Dow: Dividends Galore 11:09 a.m. Dec. 4, 2013 - 247WallSt.com
Medicines Co. Acquires Rempex Pharma; Street Applauds 10:21 a.m. Dec. 4, 2013 - Investors Business Daily
Stock Market News for December 4, 2013 - Market News 10:06 a.m. Dec. 4, 2013 - Zacks.com
Best Biotech CEO of 2013: Your Vote Counts 8:07 a.m. Dec. 4, 2013 - TheStreet.com
Pfizer Inc (PFE): Today's Featured Drugs Laggard 5:03 p.m. Dec. 3, 2013 - TheStreet.com
Dow Today: Pfizer (PFE) Lower 1:30 p.m. Dec. 3, 2013 - TheStreet.com
PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst 10:01 a.m. Dec. 3, 2013 - Seeking Alpha
Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More 8:29 a.m. Dec. 3, 2013 - 247WallSt.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pfizer Expands Clinical Trial Data Access Policy And Launches Data Access Portal 12:09 p.m. Dec. 4, 2013 - BusinessWire
Bullish Stocks Commentary: Pfizer Inc, Zynga Inc, OCZ Technology Group, EnteroMedics Inc 9:01 a.m. Dec. 4, 2013 - ACCESSWIRE
Traders Buzz: Pfizer Inc, Chesapeake Energy Corporation, Alcatel Lucent SA, Advanced Micro Devices 10:02 a.m. Dec. 3, 2013 - ACCESSWIRE
Pfizer Acquires Polocard, Poland's Leading Over-The-Counter Heart Attack Prevention Brand 8:30 a.m. Dec. 2, 2013 - BusinessWire
New Products, Positive Clinical Trial Results, FDA Submissions and Stock Price Updates - Research Report on Pfizer, Cubist, Zoetis, Edwards Lifesciences, and C.R. Bard 8:00 a.m. Nov. 28, 2013 - PR Newswire
FDA Approvals, New Appointments, and Official Statements - Research Report on Pfizer, Aetna, Lilly, GSK, and Sanofi 8:00 a.m. Nov. 27, 2013 - PR Newswire
Just in Time for Peak Travel Season, Introducing New Robitussin(R) DM Max Liquid-Filled Capsules 9:00 a.m. Nov. 25, 2013 - BusinessWire
Upcoming Conference Schedules, Orphan Drug Designations and Stock Price Updates - Research Report on Pfizer, ICU Medical, CONMED, Gentium, and Repros Therapeutics 8:00 a.m. Nov. 25, 2013 - PR Newswire
Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV 9:00 a.m. Nov. 22, 2013 - PR Newswire
Pfizer's XALKORI(R) Granted Regular FDA Approval 11:00 a.m. Nov. 21, 2013 - BusinessWire
Pfizer and GSK to Initiate Study of Novel Combination Therapy in Patients with Melanoma 8:00 a.m. Nov. 21, 2013 - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Nov. 21, 2013 - PR Newswire
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer 7:00 a.m. Nov. 21, 2013 - GlobeNewswire
Notes Redemption, Upcoming Presentations, and Manufacturing Investments - Research Report on Pfizer, Baxter, Lilly, UnitedHealth Group, and Align Technology 8:00 a.m. Nov. 19, 2013 - PR Newswire
Pfizer Announces FDA Approval of Supplemental Application to Expand XELJANZ(R) (tofacitinib citrate) Labeling to Include Additional Patient-Reported Outcomes Data for Adults with Moderately to Severely Active Rheumatoid Arthritis 4:47 p.m. Nov. 18, 2013 - BusinessWire
Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 6:21 p.m. Nov. 14, 2013 - PR Newswire
Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014 8:30 a.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Athersys Recognized Among Fastest Growing Companies in North America on Deloitte's 2013 Technology Fast 500(TM) 2:00 p.m. Nov. 13, 2013 - GlobeNewswire
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
A tale of two drug companies 4:13 p.m. Dec. 5, 2013 - Mark Hulbert
3 low-risk stocks for market skeptics 6:15 a.m. Dec. 5, 2013 - Jeff Reeves
DuPont, Pfizer are top decliners in Dow index 4:01 p.m. Dec. 3, 2013 - Polya Lesova
Large-caps can boost your portfolio at year-end 2:58 p.m. Nov. 22, 2013 - Mark Hulbert
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
Where's the market oopmh? Cisco and a turnaround on Exxon Mobil 8:45 a.m. Nov. 13, 2013 - blogs.marketwatch.com
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch
U.S. stocks open higher; Pfizer rises 1% 9:36 a.m. Oct. 29, 2013 - Victor Reklaitis
Stock futures up slightly ahead of Fed meeting 9:04 a.m. Oct. 29, 2013 - Sara Sjolin
Pfizer profit falls, adjusts full-year views 7:24 a.m. Oct. 29, 2013 - MarketWatch.com
Pfizer net falls, adjusts full-year earnings range 7:18 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 revenue down 2% to $12.64 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 profit falls 19% to $2.59 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Adopts PhRMA’s Transparency Prescription 3:47 p.m. Dec. 5, 2013 - Wall St. Cheat Sheet
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy 12:43 p.m. Dec. 5, 2013 - Seeking Alpha
Pfizer to broaden access to clinical trial data 12:40 p.m. Dec. 5, 2013 - Seeking Alpha
Breast Cancer Drug Data Boosts Puma Biotechnology 10:15 a.m. Dec. 5, 2013 - Investors Business Daily
Goldman Sachs Removes Pfizer And Adds AbbVie To Its Conviction Buy List: Should You? 7:50 a.m. Dec. 5, 2013 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Stocks vs. Bonds 8:24 p.m. Dec. 4, 2013 - TheStreet.com
Companies Say Goodbye to the 'Burbs 8:21 p.m. Dec. 4, 2013 - WSJ.com
Pfizer: Transformation Pace And Oncology Success Determine Potential Returns 4:40 p.m. Dec. 4, 2013 - Seeking Alpha
Pfizer cuts 150 jobs in Ireland 3:16 p.m. Dec. 4, 2013 - Seeking Alpha
Pfizer Expands Clinical Trial Data Access Policy, Launches Data Access Portal 11:10 a.m. Dec. 4, 2013 - benzinga.com
Meet the Preliminary 2014 Dogs of the Dow: Dividends Galore 11:09 a.m. Dec. 4, 2013 - 247WallSt.com
Medicines Co. Acquires Rempex Pharma; Street Applauds 10:21 a.m. Dec. 4, 2013 - Investors Business Daily
Stock Market News for December 4, 2013 - Market News 10:06 a.m. Dec. 4, 2013 - Zacks.com
Best Biotech CEO of 2013: Your Vote Counts 8:07 a.m. Dec. 4, 2013 - TheStreet.com
Pfizer Inc (PFE): Today's Featured Drugs Laggard 5:03 p.m. Dec. 3, 2013 - TheStreet.com
Dow Today: Pfizer (PFE) Lower 1:30 p.m. Dec. 3, 2013 - TheStreet.com
PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst 10:01 a.m. Dec. 3, 2013 - Seeking Alpha
Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More 8:29 a.m. Dec. 3, 2013 - 247WallSt.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pfizer Expands Clinical Trial Data Access Policy And Launches Data Access Portal 12:09 p.m. Dec. 4, 2013 - BusinessWire
Bullish Stocks Commentary: Pfizer Inc, Zynga Inc, OCZ Technology Group, EnteroMedics Inc 9:01 a.m. Dec. 4, 2013 - ACCESSWIRE
Traders Buzz: Pfizer Inc, Chesapeake Energy Corporation, Alcatel Lucent SA, Advanced Micro Devices 10:02 a.m. Dec. 3, 2013 - ACCESSWIRE
Pfizer Acquires Polocard, Poland's Leading Over-The-Counter Heart Attack Prevention Brand 8:30 a.m. Dec. 2, 2013 - BusinessWire
New Products, Positive Clinical Trial Results, FDA Submissions and Stock Price Updates - Research Report on Pfizer, Cubist, Zoetis, Edwards Lifesciences, and C.R. Bard 8:00 a.m. Nov. 28, 2013 - PR Newswire
FDA Approvals, New Appointments, and Official Statements - Research Report on Pfizer, Aetna, Lilly, GSK, and Sanofi 8:00 a.m. Nov. 27, 2013 - PR Newswire
Just in Time for Peak Travel Season, Introducing New Robitussin(R) DM Max Liquid-Filled Capsules 9:00 a.m. Nov. 25, 2013 - BusinessWire
Upcoming Conference Schedules, Orphan Drug Designations and Stock Price Updates - Research Report on Pfizer, ICU Medical, CONMED, Gentium, and Repros Therapeutics 8:00 a.m. Nov. 25, 2013 - PR Newswire
Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV 9:00 a.m. Nov. 22, 2013 - PR Newswire
Pfizer's XALKORI(R) Granted Regular FDA Approval 11:00 a.m. Nov. 21, 2013 - BusinessWire
Pfizer and GSK to Initiate Study of Novel Combination Therapy in Patients with Melanoma 8:00 a.m. Nov. 21, 2013 - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Nov. 21, 2013 - PR Newswire
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer 7:00 a.m. Nov. 21, 2013 - GlobeNewswire
Notes Redemption, Upcoming Presentations, and Manufacturing Investments - Research Report on Pfizer, Baxter, Lilly, UnitedHealth Group, and Align Technology 8:00 a.m. Nov. 19, 2013 - PR Newswire
Pfizer Announces FDA Approval of Supplemental Application to Expand XELJANZ(R) (tofacitinib citrate) Labeling to Include Additional Patient-Reported Outcomes Data for Adults with Moderately to Severely Active Rheumatoid Arthritis 4:47 p.m. Nov. 18, 2013 - BusinessWire
Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 6:21 p.m. Nov. 14, 2013 - PR Newswire
Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014 8:30 a.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Athersys Recognized Among Fastest Growing Companies in North America on Deloitte's 2013 Technology Fast 500(TM) 2:00 p.m. Nov. 13, 2013 - GlobeNewswire
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼